Long COVID Trial, Recruiting (NCT04736732)

Long COVID Trial, Recruiting NCT04736732 Sponsor: Emilia Falcone, MD Condition: Long COVID

Printed from Voxsanity (voxsanity.com.au) — NCT04736732 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Long Covid

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older of any gender who currently live in Quebec and speak English or French
People who have a personal email address (used to receive reminders and questionnaires)
People who have had at least one positive COVID-19 test (PCR, serology, or antibody/antigen test) within the last 60 months
People who never received a positive COVID-19 test result but had symptoms consistent with COVID-19 while living with someone who did test positive within the last 60 months
People who tested negative for COVID-19 while living with someone who tested positive, or who had close contact with COVID-19 through their work, and never experienced any COVID-19-related symptoms
People who currently have no COVID-19 symptoms, have never tested positive, and have had at least one negative COVID-19 test (PCR, serology, or antibody/antigen)
People who had an undiagnosed viral infection within the last 60 months, whether or not they have ongoing symptoms after recovering from that infection

Who may not be able to join:

People the trial's principal investigator considers not appropriate for enrollment for any reason
People with a known pregnancy (note: pregnancy testing is not automatically required at enrollment unless there is a possibility of pregnancy)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Emilia Liana Falcone, M.D., Ph.D., IRCM

Phone: 514-987-5610

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04736732

Sponsor: Emilia Falcone, MD

Phase: Not Applicable

Status: Recruiting

Condition: Long COVID

Trial contact: 514-987-5610

More information: https://clinicaltrials.gov/study/NCT04736732

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older of any gender who currently live in Quebec and speak English or French
People who have a personal email address (used to receive reminders and questionnaires)
People who have had at least one positive COVID-19 test (PCR, serology, or antibody/antigen test) within the last 60 months
People who never received a positive COVID-19 test result but had symptoms consistent with COVID-19 while living with someone who did test positive within the last 60 months
People who tested negative for COVID-19 while living with someone who tested positive, or who had close contact with COVID-19 through their work, and never experienced any COVID-19-related symptoms
People who currently have no COVID-19 symptoms, have never tested positive, and have had at least one negative COVID-19 test (PCR, serology, or antibody/antigen)
People who had an undiagnosed viral infection within the last 60 months, whether or not they have ongoing symptoms after recovering from that infection

Who may not be able to join:

People the trial's principal investigator considers not appropriate for enrollment for any reason
People with a known pregnancy (note: pregnancy testing is not automatically required at enrollment unless there is a possibility of pregnancy)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Emilia Falcone, MD

Registry

ClinicalTrials.gov

Start date

1 February 2021

Est. completion

4 May 2027

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

The development of any end-organ complication that can be plausibly related to COVID-19. The following end-organ systems will be evaluated: cardiovascular.; The development of any end-organ complication that can be plausibly related to COVID-19. The following end-organ systems will be evaluated: pulmonary.; The development of any end-organ complication that can be plausibly related to COVID-19. The following end-organ systems will be evaluated: renal.; The development of any end-organ complication that can be plausibly related to COVID-19. The following end-organ systems will be evaluated: end...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov